Diclofenac Sodium Topical Solution, 1.5% w/w, packaged in 150 mL bottles, Rx only, Mfg: SOLA Pharmaceuticals Preferred Pharmaceuticals, Inc., NDC 68788-7707-01
Published December 22, 2021 · Recall initiated: November 29, 2021
Summary
FDA records drug Class II recall D-0278-2022, published December 22, 2021 and initiated November 29, 2021. Recalling firm: Preferred Pharmaceuticals, Inc.; Status: Ongoing; Reported quantity: 72 bottles; Lot: Lot #: E1220B. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective container: Out of specification for container integrity leading to bottles leaking.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Distributor
- Distributed to 5 physician consignees located in the following states: CT, FL, and KS.
- Lot
- Lot #: E1220B
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAArtificial Tears Lubricant Eye Drops, Visine, Pkg Size: 15, Mfg: Geri-Care: Brooklyn, NY. NDC: 68788-7266-0November 11, 2026
- FDALidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro PharmaceuticalsOctober 14, 2026
- FDAArtificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 ozApril 15, 2026
- FDAOndansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged byDecember 24, 2025
- FDALidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent PharmaDecember 22, 2021
- FDAPuritan Bennett 980 Series Ventilator, 980X2ESDIECDecember 15, 2021
Questions about this recall
Was Diclofenac Sodium Topical Solution, 1.5% w/w, packaged in 150 mL bottles, Rx only, Mfg: SOLA Pharmaceuticals Preferred Pharmaceuticals, Inc., NDC 68788-7707-01 recalled?
Yes. FDA published recall D-0278-2022 on December 22, 2021. Reported hazard: Defective container: Out of specification for container integrity leading to bottles leaking.
What should I do if I have this product?
Voluntary: Firm initiated · Letter